Pablo Mandó

9PUBLICATIONS
35CO-AUTHORS
Molecular targetsLiquid biopsiesCancer diagnosisMultimorbidityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 12, 2026
BRCA and CDK4/6: allies or antagonists?-efficacy of CDK4/6 inhibitors in HR+/HER2- breast cancer with germline BRCA1/2 mutations: a narrative review.

Maria Florencia Illia, Giuliana Colucci, Andres Rodriguez Mignola

|Dec 04, 2025
Challenges and Opportunities for Cancer Clinical Trials Development in Latin America.

Juan Manuel Garzón-Dangond, Oscar Arrieta, Pablo Mandó

|Oct 22, 2025
Physician treatment decisions for hormone receptor-positive, HER2-negative early breast cancer in young patients: a Latin American survey.

Dana Narvaez, Federico Waisberg, Cynthia Villarreal-Garza

|Apr 11, 2025
Academic Collaborative Groups in Latin America: Key for High-Quality Standards and Personal and Collective Growth.

Pablo Mandó, Federico Waisberg, Gonzalo Gomez Abuin

|Feb 27, 2025
Assessing Clinical Value of New Treatment Strategies: ESMO-MCBS and ASCO-VF Evaluation in Phase III Trials at ASCO Annual Meeting 2022.

Sofie Seghers, Pablo Mandó, Marc Eid

|Nov 27, 2024
Uncovering Surgical Dynamics and Trends in Early Breast Cancer Stage at Diagnosis: Key Insights From a Two-Decade Argentine Database Analysis.

Pablo Mandó, Verónica Fabiano, Soledad Gomez Guasch

Pageof 2

Frequent Collaborators

5 joint publications

Federico Waisberg

2 joint publications

Carlos Barrios

2 joint publications

Andrés F Cardona

1 joint publications

Gerardo Cueto